换句话说，用纳米金检测疾病标志物会变得比用传统方法灵敏10万倍。
Put another way, the disease marker becomes 100,000 times more sensitive than that of conventional methods.
研究人员正在开发新的方法来促进在疾病早期过程中跟踪并监测疾病标志物，并将其作为疾病进展指标。
Researchers are developing new methods that will facilitate tracking disease markers at very early stages and monitoring them as a disease progresses.
生物标志物还能显示生物进程与疾病相关进展的变化，或者甚至是疾病进展中的危险。
Biomarkers can also reveal changes in a biological pathway that correlate with disease progression, or even the risk of disease progression.
虽然还是初步的，提供明确的调查结果证明，这种突破性技术可开发的生物标志物用于人类疾病的范围。
While still preliminary, the findings offer clear proof that this breakthrough technology could be used in the development of biomarkers for a range of human diseases.
今后应加强与胆系恶性肿瘤相关疾病的监测和处理，并力求发现敏感性和特异性均高的肿瘤标志物，以发现早期肿瘤。
To diagnose the tumor in its early stage, the monitor and management of some diseases related to BMT should be enhanced, and tumor markers with high susceptibility and specificity should be explored.
在ra病程中，血清的形态学和再吸收标志物浓度的改变指示出随着疾病的进程，骨代谢活力降低。
Serum morphogenesis and resorption markers' concentrations change in course of ra indicating the decrease in bone metabolic activity with the disease duration and progression.
巨噬细胞成像技术可以作为一种生物标志物来证实亚临床炎症损伤，可以预测未来发生疾病的风险，同时也可以用来评价新的治疗方法。
Macrophage imaging may serve as a biomarker to identify subclinical inflamed lesions, to predict future risk, and to aid in the assessment of novel therapies.
血清胃泌素是鉴别胃良恶性疾病的一个较好的标志物。
Serum gastrin is a good marker to differentiate benign and malignant gastric diseases.
两个牙周疾病的主要标志物，即牙周袋深度和临床附着丧失程度，也同时被测量。
Probing pocket depth and clinical attachment loss, two markers of periodontal disease, were also measured.
目的探讨维持性血液透析（MHD）患者血液标志物对心血管疾病预测的临床意义。
Objective To explore the clinical significance of blood markers of MHD(maitenance hemedialyses) patients to the prediction of cardiovascular disease(CVD).
结论本研究成功建立了血清蛋白质的纯化技术，为寻找疾病的血清学标志物奠定了基础。
Conclusion The established method of purifying serum proteins may be foundation in searching serology marker of diseases.
第二点是关于应用这些标志物的资料证实，活组织检查表明不是癌症的某些东西，多数情况下是早期疾病的问题。
The second point is that data on the use of these markers to prove that something you biopsy is not cancer is mainly a problem with early stage disease.
还有一个需要，以确定疾病的易感性的预后指标，生物标志物来监测疾病的进展和改进的技术新疗法的有效性。
There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies.
针对自体组织成分的自身抗体一直是自身免疫性疾病的主要诊断标志物和研究发病机制的关键环节。
Autoantibodies have long been used as diagnosis markers in autoimmune disease, and are thought to be the key point of the pathogenesis.
动脉粥样硬化是一种炎性疾病，炎症影响动脉粥样硬化斑块的稳定性和自然进程，C-反应蛋白是炎症的标志物。
Atherosclerosis is an inflammatory disease. Inflammation affects the stability and natural proceeding of atherosclerotic plaque. C - reactive protein is a marker of inflammation.
心肌损伤生物标志物的检测在心脏疾病临床诊断上被广泛应用，但是在新药的非临床安全评价方面，心肌损伤标志物的应用相对滞后。
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
临床上需要一些早期即可以测量的、敏感的、特异性的标志物来诊断疾病。
The measurable, sensitive and specific biomarkers, which can be detected in the early stage of disease, are very necessary for the diagnosis in clinics.
结论CA125不只是卵巢癌的指标，也是一种广谱肿瘤标志物，并且肝硬化等良性疾病也有较高的阳性率，可作为健康体检中筛选异常人群的指标。
Conclusion: CA125 is not only a marker for ovarian cancer, but a broad-spectrum tumor marker. There are higher positive rates of CA125 in some benign diseases including hepatocirrhosis.
降钙素原是近年来发现全身严重感染性疾病的标志物。
Procalcitonin is the sign of , whole body serious infectious disease .
该体系将同样的适用于其他的肿瘤或疾病相关的蛋白质标志物的研究。
This secreted proteins research system will be equally applicable to other tumors or disease-related protein markers.
目的：观察急性单核白血病（AML-M5）止凝血因子标志物的变化，探索AML-M5患者出血机制及这些标志物在疾病诊疗、预后判断中的意义。
Objective:To study the changes of hemostatic molecular markers inacute monoblastic leukemia (AML-M5) for elucidate the mechanism of hemorrhage and its clinical significance.
目前蛋白质组学技术在围产医学领域的研究主要侧重于疾病的发生机制、早期诊断及寻找疾病的生物标志物。
At present, the research on proteomics in field of perinatology emphasizes on mechanism, early diagnosis and searching for biomarkers of the perinatal diseases.
方法：使用多肿瘤标志物蛋白芯片检测系统检测已确诊肺癌患者、肺部良性疾病和健康体检者的肿瘤标志物信息，并进行统计学分析。
Methods:The serums level of tumor markers were detected by the C-12 system in lung cancer patients with benign pulmonary disease and healthy persons.
该技术已被用于发现新颖生物标志物和潜在的且能影响疾病进程的新靶点。
The technology has been developed to support discovery of novel biomarkers and potentially new disease-modifying targets.
该技术已被用于发现新颖生物标志物和潜在的且能影响疾病进程的新靶点。
The technology has been developed to support discovery of novel biomarkers and potentially new disease-modifying targets.
应用推荐